PF-2545920

Potent and selective phosphodiesterase 10A (PDE10A) inhibitor (IC50=1.26nM) in vitro and in vivo. PDE10A is a cGMP and cAMP degrading PDE isozyme with neurological importance and was shown to be implicated in the regulation of energy homeostasis. Inhibition of PDE10A leads to interference of the breakdown of the secondary messenger cAMP and cGMP. Anti-psychotic agent. Useful for the treatment of schizophrenia. Anticancer agent. Inhibits colon tumor cell growth for which high levels of PDE10A have been reported. Antiobesity and antidiabetic agent. Induces browning in white adipose tissue (WAT).

Price Not Available 25 mg PF-2545920 Supplier Page
Catalog Number AG-CR1-3636-M025
Alternative Name(s) 2-(4-(1-Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)-phenoxymethyl)quinoline; MP-10
Research Area Biochemicals, Cancer, Metabolism, Neurobiology, Neurodegenerative Disease, Obesity
Molecular Formula C25H20N4O
CAS# 898562-94-2
Purity >98%
Inchi InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3
Inchi Key AZEXWHKOMMASPA-UHFFFAOYSA-N
SMILES CN(C=C1C2=CC=NC=C2)N=C1C(C=C3)=CC=C3OCC4=NC5=CC=CC=C5C=C4
Size 25 mg
Supplier Page http://www.adipogen.com/ag-cr1-3636/pf-2545920.html